Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational trophoblastic tumors.

G J Rustin, K D Bagshawe

    Critical Reviews in Oncology/Hematology
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Gestational trophoblastic tumors have a high remission rate. Research explores geographical variations, immunological differences, chromosomal analysis for mole differentiation, and factors influencing progression to choriocarcinoma, alongside new chemotherapy regimens.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editorial.

    Journal of the Royal College of Physicians of London·2019
    Same author

    The management of high-risk gestational trophoblastic tumours (GTT).

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    Radioimmunoassays [abridged].

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Chemotherapy in breast cancer.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

    British journal of cancer·2010
    Same author

    Two Cases of Trophoblastic Disease.

    Proceedings of the Royal Society of Medicine·2009

    Area of Science:

    • Gynecology
    • Oncology
    • Reproductive Immunology

    Background:

    • Gestational trophoblastic tumors (GTTs) demonstrate high remission rates.
    • Significant geographical variations exist in hydatidiform mole incidence.
    • Immunological and chromosomal factors are key areas of interest.

    Purpose of the Study:

    • To review current knowledge on trophoblastic disease epidemiology and immunology.
    • To discuss pathological differentiation methods for molar subtypes.
    • To examine factors influencing GTT progression and current treatment strategies.

    Main Methods:

    • Review of epidemiological data on hydatidiform mole incidence.
    • Analysis of immunological differences in at-risk populations.
    • Discussion of chromosomal analysis in differentiating complete and partial moles.

    Related Experiment Videos

  • Evaluation of factors associated with GTT progression.
  • Assessment of chemotherapy utilization and novel treatment regimens.

    • Main Results:

    • High complete remission rates for GTTs are established.
    • Geographical variations suggest environmental or genetic influences.
    • Chromosomal analysis aids in precise pathological diagnosis.
    • Factors driving progression from mole to choriocarcinoma require further elucidation.
    • Newer chemotherapy regimens show promise for improved efficacy and reduced toxicity.

    Conclusions:

    • Trophoblastic disease research continues to evolve, focusing on etiology, diagnosis, and treatment optimization.
    • Understanding immunological and genetic factors is crucial for risk stratification.
    • Advances in chemotherapy offer better outcomes with fewer side effects for patients with GTTs.